Showing 11 - 20 of 142,857
This paper updates the cost-per-life-saved cutoff, which is a cost-effectiveness threshold for lifesaving regulations, whereby regulations costing more per life saved than this threshold level are expected to increase mortality risk on net. Two competing methods of deriving the cutoff exist: a...
Persistent link: https://www.econbiz.de/10012942209
This paper updates the cost-per-life-saved cutoff, which is a cost-effectiveness threshold for life- saving regulations, whereby regulations costing more per life saved than this threshold level are expected to increase mortality risk on net. Two competing methods of deriving the cutoff exist: a...
Persistent link: https://www.econbiz.de/10012920555
Persistent link: https://www.econbiz.de/10012230154
Intro -- DOCTORING MEDICAL GOVERNANCE: MEDICAL SELF-REGULATION IN TRANSITION -- CONTENTS -- PREFACE -- DEDICATION … Science, the Principle of Self-Regulation and the Doctrine of ClinicalAutonomy -- FROM CLUB GOVERNANCE TO STAKEHOLDER … REGULATION -- Medicine and the Establishment of the National Health Service -- Changes in the GMC: Discipline, Education and …
Persistent link: https://www.econbiz.de/10012690832
The COVID-19 is having an unprecedented impact in the commercial and trade sphere globally. Businesses of all sizes are finding it difficult to operate efficiently and many struggle to meet contractual obligations. Agency is a ubiquitous concept in trade and commerce. The sudden implosion of...
Persistent link: https://www.econbiz.de/10014101483
We evaluate the impact of California Assembly Bill 394, which mandated maximum levels of patients per nurse in the hospital setting. When the law was passed, some hospitals already met the requirements, while others did not. Thus changes in staffing ratios from the pre- to post-mandate periods...
Persistent link: https://www.econbiz.de/10011261657
The COVID-19 pandemic has exposed the fundamental flaws in the current system of medical innovation and access to medicines, which require urgent attention from the global community. This is prompted by the experience of the past decades, which has proven that this system was ineffective in...
Persistent link: https://www.econbiz.de/10013250125
This report provides an analysis of patents covering medicines in trials to treat COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the examination of the claims contained in...
Persistent link: https://www.econbiz.de/10013194325
Persistent link: https://www.econbiz.de/10012664701